Gilead Sciences generates stellar profit margins with its HIV and hepatitis C virus, or HCV, portfolio, which requires only a small salesforce and inexpensive manufacturing. We think its portfolio and pipeline support a wide moat, and with the HCV market stabilizing, Gilead needs strong continued innovation in HIV, solid oncology launches, and smart future acquisitions to return to growth.
Gilead markets several single-tablet regimens for HIV, and its next-generation products with better long-term safety profiles, led by Biktarvy, are boosting the company's market share.
Gilead's Yeztugo is a promising new HIV prevention drug, but it is unclear if markets outside the US will embrace this form of therapy.
|
Metric
|
GILD
|
ABBV
|
GSK
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.04 | 24.97 | 11.13 |
Price/Book Value | 7.09 | — | 4.42 |
Price/Sales | 5.66 | 7.18 | 2.42 |
Price/Cash Flow | 11.67 | 19.69 | 9.03 |
|
Metric
|
GILD
|
ABBV
|
GSK
|
|---|---|---|---|
Quick Ratio | 1.31 | 0.52 | 0.51 |
Current Ratio | 1.97 | 0.80 | 0.79 |
Interest Coverage | 11.33 | 2.96 | 11.71 |
|
Metric
|
GILD
|
ABBV
|
GSK
|
|---|---|---|---|
Return on Assets (Normalized) | 18.35% | 13.37% | 11.47% |
Return on Equity (Normalized) | 49.22% | — | 44.00% |
Return on Invested Capital (Normalized) | 24.23% | 29.17% | 22.62% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| LOCK|^g!Z^!N | LOCK|Ml> | $1T | |||
| Johnson & Johnson
JNJ
| LOCK|%Dg?q< | LOCK|@Ch | $609B | |||
| AbbVie Inc
ABBV
| LOCK|^%VVFZc | LOCK|#S | $450B | |||
| Roche Holding AG ADR
RHHBY
| LOCK|F#gS!dl | LOCK|>c | $330B | |||
| Merck & Co Inc
MRK
| LOCK|bzSrbS | LOCK|%x^ | $315B | |||
| Novartis AG ADR
NVS
| LOCK|pG>&!mQ | LOCK|ML% | $295B | |||
| AstraZeneca PLC
AZN
| LOCK|#$h#T>wg | LOCK|^C | $263B | |||
| Novo Nordisk AS ADR
NVO
| LOCK|!vVp!g | LOCK|t? | $223B | |||
| Amgen Inc
AMGN
| LOCK|<$bM!VCl | LOCK|^Cg | $198B |
/author-service-images-prod-us-east-1.publishing.aws.arc.pub/morningstar/558ccc7b-2d37-4a8c-babf-feca8e10da32.jpg)
United States